Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

Monday, 22 July 2019
Pharma in Focus Jobs
PiF
Latest News
MA Board meets on election
Vote timing just one matter on table for Wednesday.
Waste, IP in NMP Review
Former MA CEO suggests review have a broad focus.
Aug PBS listings underwhelm
New sizes feature in Hunt's monthly Sunday announcement.
AbbVie's new hope gets nod
Possible successor to Humira given TGA go-ahead.
Hunt pulled into Mundi row
Letter to minister bypasses TGA.
Pharmas striving to keep talent
Hiring experts in bid to minimise staff turnover.
Most Popular
Gilead Aussie exec steps down
Takes $1.5m golden handshake and walks after nine years.
IP shock coming for pharma
Law reform makes some patent and licensing deals vulnerable.
GSK vax exec to lead Seqirus
Woman named as GM to replace Gordon Naylor.
Big change for 60-year-old code
MA's code of conduct will have a different look next time around.
Pricing report flags Netflix deal
One of six new drug funding models highlighted.
Earlier
PBAC webinar spooks industry
Probe into PSD redactions too soon says MA.
Peripatetic Hunt proved costly
Q1 expenses show increased travel allowance claims.
Narcolepsy spend questioned
DUSC says Nuvigil costing PBS more than expected.
PBS growing economy says RBA
'Increased spending' on PBS boosts consumer spend.
BMS takes CT show on the road
Visiting federal MPs in push for clinical trial reform.
Approvals Action
Opiate market battle looms
Dependence options widened by new Mundipharma drug.
Pipeline Monitor
Success for Novartis, Sanofi, GSK
FDA and EU regulators make key decisions.
Top of the Hill
Price, transparency and new drugs
The challenges threatening traditional funding models.
FREE Content
What's On
Events & Conferences
Pharma Guide
SEARCH NOW
Pharma in Focus Jobs
Ascott
© 2003 - 2019 Lush Media | Privacy Statement | Subscribe to Pharma in Focus | Design: Jolly Good Design